Data Safety Monitoring Board (DSMB).
作者信息
Welch K M A
机构信息
The Chicago Medical School, USA.
出版信息
Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Sep;5 Suppl 1:46-7. doi: 10.1080/17434470410019960.
PMID:15512871
Abstract
摘要
相似文献
1
Data Safety Monitoring Board (DSMB).数据安全监测委员会（DSMB）
Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Sep;5 Suppl 1:46-7. doi: 10.1080/17434470410019960.
2
[DSMB. 2. The importance of an efficient DSMB: some examples of high-risk clinical trials].[数据安全监测委员会。2. 高效数据安全监测委员会的重要性：一些高风险临床试验的例子]
Med Sci (Paris). 2005 Feb;21(2):187-9. doi: 10.1051/medsci/2005212187.
3
Designing clinical trials in amyotrophic lateral sclerosis.肌萎缩侧索硬化症临床试验的设计
Phys Med Rehabil Clin N Am. 2008 Aug;19(3):495-508, ix. doi: 10.1016/j.pmr.2008.02.002.
4
Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board.监测妇女健康倡议的随机试验：数据与安全监测委员会的经验
Clin Trials. 2007;4(3):218-34. doi: 10.1177/1740774507079439.
5
ALS trial design: expectation and reality.肌萎缩侧索硬化症试验设计：期望与现实
Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Sep;5 Suppl 1:52-4. doi: 10.1080/17434470410019979.
6
Role of the data safety and monitoring board in an international trial.数据安全监测委员会在国际试验中的作用。
AIDS. 2007 Apr;21 Suppl 2(Suppl 2):S99-102. doi: 10.1097/01.aids.0000266462.33891.0b.
7
Baseline disease characteristics.基线疾病特征。
Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Sep;5 Suppl 1:64-7. doi: 10.1080/17434470410019924.
8
Therapeutic trials in ALS.肌萎缩侧索硬化症的治疗试验。
Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Apr;4(1):6-7. doi: 10.1080/14660820310006643.
9
FDA signals it's open to drug trials that shift midcourse.美国食品药品监督管理局表示，它对中途调整的药物试验持开放态度。
Wall St J (East Ed). 2006 Jul 10:B1, B8.
10
What is next in ALS clinical trials?肌萎缩侧索硬化症临床试验的下一步是什么？
Neurology. 2007 Aug 21;69(8):719-20. doi: 10.1212/01.wnl.0000271093.41793.ff.
Zotero 插件